HUTCHMED (China) Ltd (HCM)
HUTCHMED (China) Limited is a biopharmaceutical firm dedicated to the discovery, advancement, and marketing of innovative targeted and immune-based treatments for various cancers and immune-related disorders. Its operations are divided into two main areas: Oncology/Immunology and a segment encompassing Other Ventures. The company's reach extends from Hong Kong globally. Among its pipeline, HUTCHMED is developing Savolitinib, an inhibitor targeting non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC). Another key therapeutic, Fruquintinib, is an inhibitor being investigated for its efficacy in CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and a range of other gastrointestinal and solid tumors. Furthermore, the company's portfolio includes Surufatinib, an inhibitor applicable to numerous conditions such as neuroendocrine tumors (NETs - both pancreatic and non-pancreatic), biliary tract cancer, sarcoma, neuroendocrine neoplasm, esophageal cancer, small cell lung cancer, gastric cancer (GC), thyroid cancer, endometrial cancer (EMC), NSCLC, and general solid tumors. HMPL-523, a spleen tyrosine kinase inhibitor, is designed to treat hematological cancers and specific chronic immune conditions, while HMPL-689 targets the isoform PI3Kd (phosphoinositide 3'-kinase delta). Additional compounds in development include Tazemetostat, an EZH2 inhibitor indicated for specific epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor showing promise for hematological malignancies, gliomas, and solid tumors; HMPL-760, which functions as a Bruton's tyrosine kinase inhibitor; and HMPL-453, an inhibitor aimed at intrahepatic cholangiocarcinoma. The pipeline also features HMPL-295 for solid tumors, HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors, alongside Epitinib (HMPL-813) and Theliatinib (HMPL-309), both of which act as inhibitors. HUTCHMED maintains strategic collaboration agreements with a number of partners, including AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, BeiGene, Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The entity, established in 2000 and headquartered in Central, Hong Kong, was previously identified as Hutchison China MediTech Limited before officially adopting its current name, HUTCHMED (China) Limited, in May 2021.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
HUTCHMED (China) Limited
NASDAQ:HCMHealthcare · Drug Manufacturers - Specialty & Generic
-3.24%$13.15
AH$13.14-0.08%vs close
Mkt Cap$2.29B
Float170.46M
O/S173.81M
Vol
$ Vol
RVOL
Inst Own2.5%
SI0.2%
Earnings
Dilution
Financials Summary
Revenue$549.96M
Net Income$458.12M
Total Assets$1.75B
Free Cash Flow-$88.81M
Debt & Equity
Debt 7%
Equity 93%
Total Debt$97.89M
Total Equity$1.24B
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:50Reverse splitApr 20, 200950 shares → 1
Balance Sheet Details
Assets$1.75B
Liabilities$501.84M
Accounts Receivable$147.83M
Accounts Payable$45.53M
Inventory$41.13M
PP&E (Net)$97.65M
Goodwill$3.11M
Intangible Assets$8.94M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 |
| Revenue | $549.96M | $630.2M | $838M | $426.41M | $356.13M | $228.37M | $204.89M | $214.11M | $241.2M | $216.08M | $178.2M | $87.33M | $45.97M | $22.37M | $165.03M | $134.51M | $111M | $86.97M | $65.11M | $50.43M | $37.86M | $17.5M |
| YoY Growth | -12.7% | -24.8% | 96.5% | 19.7% | 55.9% | 11.5% | -4.3% | -11.2% | 11.6% | 21.3% | 104.1% | 90.0% | 105.5% | -86.4% | 22.7% | 21.2% | 27.6% | 33.6% | 29.1% | 33.2% | 116.3% | - |
| Cost of Revenue | $337.24M | $347.63M | $384.45M | $311.1M | $28.79M | $188.84M | $160.15M | $143.94M | $175.82M | $156.33M | $110.78M | $58.85M | $22.21M | $12.75M | $74.16M | $54.64M | $44.59M | $36.13M | $27.66M | $21.32M | $14.62M | $6.14M |
| Gross Profit | $212.72M | $282.57M | $453.55M | $115.31M | $327.34M | $39.52M | $44.74M | $70.17M | $65.38M | $59.75M | $67.43M | $28.48M | $23.76M | $9.61M | $91.11M | $79.87M | $66.41M | $50.84M | $37.45M | $29.11M | $23.24M | $11.36M |
| Gross Margin | 38.7% | 44.8% | 54.1% | 27.0% | 91.9% | 17.3% | 21.8% | 32.8% | 27.1% | 27.7% | 37.8% | 32.6% | 51.7% | 43.0% | 55.2% | 59.4% | 59.8% | 58.5% | 57.5% | 57.7% | 61.4% | 64.9% |
| Research and Development | $164.15M | $213.37M | $303.06M | $386.89M | $299.09M | $176.69M | $91.94M | $115.58M | $75.78M | $66.87M | $47.37M | $29.91M | $4.48M | $5.89M | $7.29M | $6.41M | $3.86M | $8.81M | $5.64M | $2.77M | $2.05M | $1.16M |
| Selling, General, and Administrative | $103.3M | $112.91M | $133.18M | $136.11M | $127.13M | $61.45M | $52.93M | $48.65M | $43.28M | $39.58M | $29.83M | $16.82M | $24.75M | $27.07M | $56.5M | $52.7M | $44.81M | $31.74M | $23.09M | $16.04M | $18.2M | $16.44M |
| Other | $0 | $0 | $0 | $311.1M | $258.23M | $0 | $52.38M | -$1.42M | -$256K | $139K | $0 | $0 | -$17.02M | -$30.4M | $20.53M | $23.35M | $22.36M | $24.43M | $18.62M | $15.68M | $8.73M | $143K |
| Total Operating Expenses | $267.45M | $326.28M | $436.23M | $834.1M | $684.45M | $238.14M | $197.26M | $162.81M | $118.8M | $106.59M | $77.2M | $46.74M | $12.21M | $2.56M | $84.32M | $82.46M | $71.03M | $64.98M | $47.36M | $34.5M | $28.97M | $17.74M |
| Operating Income (EBIT) | -$54.73M | -$43.7M | $18.38M | -$718.8M | -$357.1M | -$198.62M | -$152.78M | -$92.64M | -$53.42M | -$46.7M | -$9.77M | -$18.23M | -$1.04M | -$17.43M | $4.12M | -$2.21M | -$4.61M | -$14.23M | -$9.72M | -$5.38M | -$5.73M | -$6.38M |
| Operating Margin | -10.0% | -6.9% | 2.2% | -168.6% | -100.3% | -87.0% | -74.6% | -43.3% | -22.1% | -21.6% | -5.5% | -20.9% | -2.3% | -77.9% | 2.5% | -1.6% | -4.2% | -16.4% | -14.9% | -10.7% | -15.1% | -36.4% |
| Interest Expense | $2.87M | $2.87M | $759K | $652K | $592K | $788K | $1.03M | $1.01M | $1.46M | $1.63M | $1.4M | $1.52M | $1.49M | $1.16M | $561K | $402K | $399K | $528K | $299K | $389K | $495K | $364K |
| Interest Income | $50.01M | $40.08M | $36.15M | $9.6M | $2.08M | $3.24M | $4.94M | $5.98M | $1.22M | $502K | $451K | $559K | $451K | $387K | $134K | $225K | $283K | $1.22M | $938K | $560K | $175K | $98K |
| Other Income (Expense) | $577.45M | $89.07M | $87.23M | $358.13M | $201.98M | $87.74M | $52.2M | $25.32M | $33.53M | $65.58M | $21.8M | $13.48M | -$1.49M | $29.31M | $711K | -$402K | -$399K | -$528K | -$299K | -$387K | -$502K | -$947K |
| Income Before Tax (EBT) | $522.72M | $45.36M | $105.6M | -$360.67M | -$155.12M | -$110.88M | -$100.58M | -$67.32M | -$19.88M | $18.89M | $12.03M | -$4.78M | $10.07M | $11.88M | $4.83M | -$2.61M | -$5.01M | -$14.76M | -$10.02M | -$5.77M | -$6.23M | -$7.32M |
| Income Tax Expense | $63.78M | $7.19M | $4.51M | -$283K | $11.92M | $4.84M | $3.27M | $3.96M | $3.08M | $4.33M | $1.6M | $1.34M | $1.05M | $1.12M | $3.14M | $2.58M | $2.07M | $1.5M | $837K | $2K | $141K | $53K |
| Net Income | $458.12M | $37.73M | $100.78M | -$360.83M | -$194.65M | -$125.95M | -$106.02M | -$74.81M | -$26.74M | $11.7M | $7.99M | -$32.82M | $5.92M | $3.64M | $710K | -$6.86M | -$8.75M | -$17.76M | -$17.19M | -$9.61M | -$6.78M | -$6.72M |
| Net Income Margin | 83.3% | 6.0% | 12.0% | -84.6% | -54.7% | -55.2% | -51.7% | -34.9% | -11.1% | 5.4% | 4.5% | -37.6% | 12.9% | 16.3% | 0.4% | -5.1% | -7.9% | -20.4% | -26.4% | -19.0% | -17.9% | -38.4% |
| Supplementary Data | ||||||||||||||||||||||
| EPS | 2.65 | 0.22 | 0.60 | -2.15 | -1.25 | -4.50 | -0.80 | -0.55 | -0.22 | 0.10 | -0.32 | -0.33 | 0.06 | 0.04 | 0.01 | -0.07 | -0.09 | -0.17 | -0.17 | -0.10 | -0.09 | -0.07 |
| Diluted EPS | 2.60 | 0.22 | 0.60 | -2.15 | -1.25 | -4.50 | -0.80 | -0.55 | -0.22 | 0.10 | -0.32 | -0.33 | 0.06 | 0.03 | 0.01 | -0.07 | -0.09 | -0.17 | -0.17 | -0.10 | -0.09 | -0.07 |
| Weighted Average OS | 171.66M | 171.07M | 169.93M | 169.43M | 158.54M | 27.92M | 133.14M | 132.85M | 123.43M | 119.43M | 109.32M | 105.13M | 104.10M | 103.84M | 103.49M | 103.06M | 102.46M | 102.46M | 102.43M | 91.43M | 73.33M | 102.42M |
| EBITDA | -$41.42M | -$31.36M | $26.58M | -$351.35M | -$147.34M | -$192.56M | -$135.13M | -$82.06M | -$49.5M | -$43.36M | -$7.76M | -$16.97M | $12.05M | $14.07M | $11.32M | $2.37M | -$47K | -$9.58M | -$5.92M | -$2.51M | -$3.42M | -$5.24M |
| EBITDA Margin | -7.5% | -5.0% | 3.2% | -82.4% | -41.4% | -84.3% | -66.0% | -38.3% | -20.5% | -20.1% | -4.4% | -19.4% | 26.2% | 62.9% | 6.9% | 1.8% | -0.0% | -11.0% | -9.1% | -5.0% | -9.0% | -29.9% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 |
| Assets | |||||||||||||||||||||
| Current Assets | |||||||||||||||||||||
| Cash and Cash Equivalents | $71.33M | $153.96M | $283.59M | $313.28M | $377.54M | $235.63M | $121.16M | $86.04M | $85.27M | $79.43M | $31.94M | $38.95M | $46.86M | $30.77M | $53.76M | $45.31M | $41.75M | $38.21M | $53.34M | $10.07M | $5.62M |
| Short-Term Investments | $1.3B | $682.15M | $602.75M | $317.72M | $634.16M | $199.55M | $96.01M | $214.91M | $273.03M | $24.27M | $0 | $12.18M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $60.54M | $0 |
| Cash and Short-Term Investments | $1.37B | $836.11M | $886.34M | $631M | $1.01B | $435.18M | $217.17M | $300.95M | $358.3M | $103.7M | $31.94M | $51.13M | $46.86M | $30.77M | $53.76M | $45.31M | $41.75M | $38.21M | $53.34M | $70.61M | $5.62M |
| Accounts Receivable | $147.83M | $167.74M | $150.46M | $126.72M | $147.73M | $47.87M | $77.17M | $43.85M | $57.25M | $48.55M | $45.82M | $32.44M | $14.79M | $10.7M | $53.09M | $30.74M | $24.63M | $25M | $23.38M | $18.7M | $15.68M |
| Inventory | $41.13M | $50.4M | $50.26M | $56.69M | $35.76M | $19.77M | $16.21M | $12.31M | $11.79M | $12.82M | $9.55M | $4.41M | $1.42M | $1.59M | $28.72M | $26.63M | $17.48M | $14.71M | $11.72M | $9.49M | $8.68M |
| Other Current Assets | $2.77M | $3.3M | $2.68M | $3.15M | $2.76M | $20.89M | $2.71M | $8.33M | $1.37M | $991K | $866K | $1.58M | $1.99M | $1.58M | $5.06M | $0 | -$142 | -$245 | -$2.2M | $18.69M | $1K |
| Total Current Assets | $1.57B | $1.07B | $1.1B | $839.89M | $1.21B | $530.74M | $317.02M | $370.54M | $432.19M | $167.38M | $89.67M | $89.84M | $67.03M | $44.64M | $140.64M | $107.76M | $83.86M | $77.92M | $88.44M | $98.8M | $29.97M |
| Long-Term Assets | |||||||||||||||||||||
| Property, Plant & Equipment Net | $97.65M | $97M | $104.39M | $84.67M | $66.32M | $45.31M | $27.48M | $17.79M | $15.48M | $11.17M | $9.85M | $8.92M | $6.54M | $33.29M | $29.45M | $29.93M | $30.65M | $32.03M | $31.51M | $27.1M | $22.01M |
| Goodwill | $3.11M | $2.99M | $3.06M | $3.14M | $3.38M | $3.31M | $3.11M | $3.19M | $3.31M | $3.14M | $3.33M | $1.95M | $407K | $8.31M | $8.25M | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $8.94M | $0 | $21K | $85K | $163K | $227K | $275K | $347K | $430K | $469K | $571K | $666K | $407K | $15.59M | $14.86M | $18.02M | $12.48M | $7.53M | $7.22M | $7.02M | $6.81M |
| Long-Term Investments | $52.25M | $0 | $48.41M | $73.78M | -$557.68M | -$60.04M | $2.93M | -$76.6M | $144.24M | $158.51M | $119.76M | $107.98M | $111.41M | $32K | $31K | -$1.21M | -$614K | -$332K | -$257K | $128K | $4.09M |
| Deferred Tax Assets | $12.66M | $12.45M | $15.46M | $15.37M | $9.4M | $1.51M | $815K | $580K | $633K | $0 | $0 | $257K | $285K | $1.64M | $1.55M | $1.21M | $614K | $332K | $257K | $10.07M | $5.62M |
| Other Long-Term Assets | $11.15M | $95.21M | $11.59M | $12.52M | $639M | $203.06M | $113.48M | $216.27M | $1.65M | $1.77M | $6.58M | $1.22M | $0 | $56.23M | $84 | $4.21M | $760K | $477K | $392K | -$10.07M | -$5.62M |
| Total Long-Term Assets | $185.76M | $207.64M | $182.93M | $189.56M | $160.59M | $193.38M | $148.1M | $161.58M | $165.74M | $175.06M | $140.09M | $120.99M | $118.63M | $115.08M | $54.14M | $52.17M | $43.9M | $40.03M | $39.12M | $34.25M | $32.91M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724.12M | $465.12M | $532.12M | $597.93M | $342.44M | $229.75M | $210.83M | $185.67M | $159.72M | $194.77M | $159.93M | $127.75M | $117.96M | $127.56M | $133.04M | $62.88M |
| Liabilities | |||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||
| Accounts Payable | $45.53M | $42.52M | $36.33M | $71.11M | $41.18M | $31.61M | $23.96M | $25.63M | $24.36M | $35.54M | $24.09M | $20.43M | $4.16M | $3.18M | $16.45M | $10.56M | $8.17M | $5.29M | $5.3M | $3.18M | $3.94M |
| Short-Term Debt | $24.97M | $23.37M | $31.16M | $3.71M | $26.91M | $3.19M | $366K | $432K | $31.99M | $22.19M | $27.4M | $34.98M | $58.88M | $10.89M | $30.04M | $24.5M | $8.11M | $7.61M | $6.56M | $7.12M | $7.39M |
| Current Income Tax Payable | $0 | $1.55M | $2.58M | $1.11M | $15.55M | $1.12M | $1.83M | $555K | $979K | $274K | $442K | $122K | $0 | $951K | $1.07M | $1.24M | $724K | $537K | $550K | $0 | $0 |
| Current Unearned Revenue | $31.42M | $0 | $57.64M | $13.35M | $15.55M | $1.6M | $2.11M | $2.54M | $2.58M | $1.86M | $1.17M | $2.39M | $3.12M | $4.55M | $4.55M | -$10.56M | -$8.17M | -$5.29M | -$5.3M | $0 | $0 |
| Other Current Liabilities | $179.82M | $290.08M | $228.93M | $222.18M | $40.95M | $8.47M | $8.09M | $8.43M | $9.34M | $5.21M | $22.13M | $13.36M | $3.9M | $14.77M | $13.76M | $38.13M | $37.26M | $22.45M | $20.97M | $5.18M | $79.57M |
| Total Current Liabilities | $315.78M | $376.56M | $403.03M | $353.9M | $311.66M | $158.4M | $113.1M | $85.48M | $104.6M | $95.12M | $81.06M | $75.3M | $78.43M | $35.61M | $88.48M | $67.65M | $49.87M | $33.24M | $29.96M | $23.06M | $90.89M |
| Long-Term Liabilities | |||||||||||||||||||||
| Long-Term Debt | $68.19M | $59.43M | $48.19M | $18.1M | $0 | $26.86M | $26.82M | $27.32M | $579K | $34.96M | $26.77M | $26.92M | $0 | $39.39M | $0 | $0 | $146K | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $20.13M | $48.43M | $69.48M | $190K | -$2.77M | $484K | $133K | $1.95M | $2.8M | $4.3M | $5.63M | $4.18M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $255K | $2.99M | $1.48M | $2.71M | $2.77M | $5.06M | $3.16M | $4.84M | $4.45M | $4M | $3.42M | $2.63M | $2.4M | $2.53M | $1.91M | $1.4M | $828K | $289K | $0 | $0 | $0 |
| Other Long-Term Liabilities | $95.63M | $10.84M | $11.35M | $12.47M | $14.33M | $8.3M | $5.96M | $280K | $538K | $0 | $10.6M | $3.85M | $0 | $0 | $27.06M | $22.07M | $1.62M | $0 | -$256K | $0 | $0 |
| Total Long-Term Liabilities | $186.06M | $125.78M | $133.36M | $38.67M | $21.49M | $46.77M | $39.12M | $34.38M | $8.37M | $43.26M | $46.41M | $37.58M | $2.4M | $41.92M | $28.97M | $23.47M | $2.59M | $289K | -$256K | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $501.84M | $502.34M | $536.39M | $392.57M | $333.15M | $205.17M | $152.22M | $119.86M | $112.97M | $138.38M | $127.48M | $112.88M | $80.83M | $77.53M | $117.44M | $91.12M | $52.45M | $33.53M | $29.96M | $23.06M | $90.89M |
| Stockholders' Equity | |||||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $87.23M | $87.16M | $87.13M | $86.48M | $86.45M | $72.77M | $66.69M | $66.66M | $66.45M | $60.71M | $56.53M | $53.08M | $52.05M | $52.05M | $51.74M | $51.74M | $51.28M | $51.23M | $51.23M | $51.21M | $0 |
| Retained Earnings | -$378.64M | -$833.17M | -$870.87M | -$971.48M | -$610.33M | -$415.59M | -$289.73M | -$183M | -$107.1M | -$80.36M | -$92.04M | -$100.05M | -$74.45M | -$89.99M | -$93.81M | -$94.73M | -$86.88M | -$78.01M | -$60.48M | -$43.78M | -$34.14M |
| Comprehensive Income & Other | -$4.53M | $0 | -$8.16M | -$1.9M | $5.57M | $4.48M | -$3.85M | -$243K | $5.43M | -$4.28M | $5.01M | $9.87M | $17.59M | $14.85M | -$32.8M | $9.58M | $9.96M | $10.58M | $8.19M | $0 | $0 |
| Other Stockholders' Equity | $1.53B | $1.51B | $1.51B | $1.5B | $1.51B | $826.93M | $511.06M | $505.34M | $502.39M | $203.92M | $118.86M | $86.13M | $111.27M | $108.52M | $106.85M | $102.54M | $101.5M | $101.93M | $99.55M | $95.52M | $473K |
| Total Equity | $1.24B | $759.93M | $730.54M | $610.37M | $986.89M | $484.12M | $288.01M | $389M | $461.73M | $184.27M | $83.36M | $39.15M | $88.87M | $70.58M | $64.78M | $59.55M | $65.9M | $75.14M | $90.3M | $102.95M | -$33.67M |
| Minority Interest | $13.34M | $11.92M | $12.85M | $26.5M | $52.62M | $34.83M | $24.89M | $23.26M | $23.23M | $19.79M | $18.92M | $58.8M | $15.97M | $13.07M | $12.54M | $9.25M | $9.4M | $9.28M | $7.31M | $7.03M | $5.66M |
| Total Liabilities and Equity | $1.74B | $1.26B | $1.27B | $1B | $1.32B | $689.28M | $440.23M | $508.86M | $574.7M | $322.65M | $210.83M | $152.03M | $169.7M | $148.1M | $182.23M | $150.67M | $118.36M | $108.67M | $120.25M | $126.01M | $57.22M |
| Supplementary Data | |||||||||||||||||||||
| Total Debt | $97.89M | $89.82M | $86.13M | $27.01M | $38.98M | $38.9M | $33.45M | $27.75M | $32.57M | $57.15M | $63.75M | $61.9M | $58.88M | $50.28M | $30.04M | $24.5M | $8.26M | $7.61M | $6.56M | $7.12M | $7.39M |
| Net Debt | $26.56M | -$64.14M | -$197.46M | -$286.27M | -$338.56M | -$196.73M | -$87.71M | -$58.29M | -$52.7M | -$22.28M | $18.06M | $22.95M | $12.02M | $19.52M | -$23.72M | -$20.81M | -$33.49M | -$30.6M | -$46.78M | -$2.95M | $1.77M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 |
| Operating Activities | ||||||||||||||||||||||
| Net Income | $457.73M | $37.73M | $100.78M | -$360.39M | -$167.04M | -$115.52M | -$103.68M | -$71.29M | -$22.96M | $14.56M | $10.43M | $7.28M | $7.04M | $3.54M | $5.39M | -$2.21M | -$4.61M | -$14.23M | -$9.72M | -$5.38M | -$5.73M | -$6.72M |
| Depreciation & Amortization | $13.31M | $12.34M | $8.21M | $8.66M | $7.19M | $6.06M | $4.94M | $3.59M | $2.58M | $2.34M | $2.02M | $1.26M | $963K | $1.5M | $4.56M | $4.58M | $4.57M | $4.65M | $3.8M | $2.87M | $2.32M | $1.72M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $552K | -$10.27M | $17.68M | $20.82M | -$33.22M | -$15.56M | $1.41M | $1.05M | -$8.83M | $0 | -$1.9M | -$1.09M | -$4M | -$12.1M | -$5.81M | $0 | $0 |
| Stock-Based Compensation | $15.29M | $21.61M | $36.6M | $30.59M | $41.99M | $19.64M | $11.59M | $10.13M | $4.74M | $3.44M | $1.46M | $868K | $357K | $752K | $943K | $279K | $150K | $955K | $2.46M | $2.37M | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||||||||||
| Accounts Receivable | $24.22M | -$41.57M | -$13.05M | -$2.38M | -$41.39M | -$4.69M | -$553K | -$486K | $2.52M | -$7.26M | -$12.03M | $5.46M | -$3.94M | $7.15M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$354K |
| Inventory | $9.54M | -$772K | $4.13M | -$21.21M | -$16M | -$3.62M | -$4.21M | -$557K | $1.05M | -$3.43M | -$5.15M | $167K | -$55K | -$72K | -$2.24M | -$9.33M | -$2.83M | -$3.22M | -$2.42M | -$185K | -$2.38M | -$368K |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $7.65M | -$1.66M | $0 | $0 | $9.82M | $3.66M | $2.17M | $980K | $2.45M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5.62M |
| Other Working Capital | -$94.63M | -$19.82M | $80.06M | $82.3M | $89.85M | $29.94M | $22.54M | $7.18M | -$6.01M | $4.09M | $3.29M | $492K | -$1.33M | $6M | -$246K | -$11.65M | $15.21M | $384K | $3.9M | $134K | -$6.94M | $0 |
| Total Working Capital Change | -$60.86M | -$62.17M | $71.15M | $58.7M | $32.46M | $29.27M | $16.11M | $6.14M | -$2.44M | $3.22M | -$10.23M | $8.29M | -$4.35M | $15.52M | -$2.49M | -$20.98M | $12.37M | -$2.84M | $1.48M | -$51K | -$9.31M | -$6.34M |
| Other Non-Cash Items | -$490.13M | -$9.01M | $2.21M | -$6.17M | -$118.82M | -$2.08M | $394K | $895K | -$11.68M | $92K | $2.5M | -$5.75M | -$32K | $3.18M | -$3.21M | $416K | $243K | $1.2M | $5.48M | $2.37M | -$876K | $1.27M |
| Net Cash from Operating | -$64.66M | $497K | $219.26M | -$268.6M | -$204.22M | -$62.07M | -$80.91M | -$32.85M | -$8.94M | -$9.57M | -$9.38M | $13.36M | $5.03M | $15.66M | $5.2M | -$19.82M | $11.63M | -$14.27M | -$8.6M | -$3.64M | -$13.6M | -$10.07M |
| Investing Activities | ||||||||||||||||||||||
| Capital Expenditures | -$14.15M | -$17.93M | -$32.61M | -$36.66M | -$16.76M | -$19.58M | -$8.56M | -$6.36M | -$5.02M | -$4.33M | -$3.32M | -$3.73M | -$2.5M | -$12.08M | -$6.3M | -$8.71M | -$7.5M | -$3.4M | -$7.24M | -$2.63M | -$1.78M | -$3.04M |
| Acquisitions | $608.5M | $0 | -$2.99M | $324K | $0 | $0 | $8.69M | $0 | $0 | $0 | $0 | $689K | $0 | $0 | $385K | -$2.66M | -$406K | $0 | $0 | -$20K | -$14.52M | $0 |
| Purchases of Investments | -$2.74B | -$1.85B | -$1.63B | -$1.2B | -$1.37B | -$732.91M | -$478.14M | -$911.55M | -$332.03M | -$85.86M | $12.18M | -$12.18M | $0 | $0 | $0 | $9K | $0 | $0 | $0 | -$124K | $0 | $0 |
| Sales of Investments | $2.13B | $1.77B | $1.34B | $1.52B | $921.36M | $629.37M | $597.04M | $961.67M | $76.27M | $56.59M | $12.18M | $0 | $0 | $0 | $0 | $146K | $0 | $0 | $0 | $560K | $0 | $0 |
| Other Investing Activities | -$9.97M | $1.28M | $29.5M | $16.49M | $160.05M | -$2.33M | $0 | $0 | $0 | $0 | -$12.18M | -$5M | $0 | $103K | $137K | $225K | $291K | $1.24M | $938K | $29K | -$11.57M | $0 |
| Net Cash from Investing | -$29.41M | -$96.06M | -$291.14M | $296.59M | -$306.32M | -$125.44M | $119.03M | $43.75M | -$260.78M | -$33.6M | $8.86M | -$20.22M | -$2.5M | -$11.98M | -$5.78M | -$10.98M | -$7.62M | -$2.16M | -$6.3M | -$2.18M | -$27.87M | -$3.04M |
| Financing Activities | ||||||||||||||||||||||
| Debt Repaid | -$6.26M | -$5.61M | -$61.7M | $9.17M | $579K | - | $116K | $3.08M | $16.95M | $3.08M | $3.21M | $3.07M | - | -$27.92M | -$8.48M | -$16.24M | -$652K | -$604K | $950K | $563K | -$14K | - |
| Common Stock Issuance | $1.58M | $790K | $5.09M | $174K | $717.32M | $318.93M | $251K | $3.87M | $301.68M | $0 | $1.43M | $2.8M | $7K | $629K | $0 | $780K | $91K | $0 | $38K | $68.74M | $0 | $0 |
| Common Stock Repurchases | $0 | -$36.06M | -$9.07M | -$48.08M | -$27.31M | -$12.9M | -$346K | -$5.45M | -$1.37M | -$604K | -$1.79M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$538K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$1M | -$9.07M | -$25.68M | -$39.4M | -$9.63M | -$965K | -$3.57M | -$1.59M | -$1.37M | -$480K | -$370K | -$577K | $1.52M | $340K | $16.94M | -$1.41M | $462K | -$1.75M | $2.6M | $30.33M | $19.01M |
| Net Cash from Financing | $7.84M | -$30.67M | $48.66M | -$82.76M | $650.03M | $296.43M | -$1.49M | -$8.23M | $273.2M | $92.44M | -$5.47M | -$641K | $13.12M | $4.17M | $7.88M | $33.96M | -$673K | $1.07M | -$2.66M | $70.66M | $30.34M | $26.24M |
| Forex Effect | $3.6M | -$3.4M | -$6.47M | -$9.49M | $2.43M | $5.55M | -$1.5M | -$1.9M | $2.36M | -$1.78M | -$1M | -$417K | $445K | $388K | $1.15M | $396K | $210K | $222K | $289K | $155K | $466K | $0 |
| Net Change in Cash | -$82.63M | -$129.63M | -$29.69M | -$64.26M | $141.91M | $114.47M | $35.12M | $771K | $5.83M | $47.49M | -$7M | -$7.92M | $16.1M | $8.25M | $8.45M | $3.56M | $3.55M | -$15.14M | -$17.27M | $65M | -$10.66M | $0 |
| Supplementary Data | ||||||||||||||||||||||
| Operating Cash Flow | -$64.66M | $497K | $219.26M | -$268.6M | -$204.22M | -$62.07M | -$80.91M | -$32.85M | -$8.94M | -$9.57M | -$9.38M | $13.36M | $5.03M | $15.66M | $5.2M | -$19.82M | $11.63M | -$14.27M | -$8.6M | -$3.64M | -$13.6M | -$10.07M |
| Capital Expenditure | -$24.15M | -$17.93M | -$32.61M | -$36.66M | -$16.76M | -$19.58M | -$8.56M | -$6.36M | -$5.02M | -$4.33M | -$3.32M | -$3.73M | -$2.5M | -$12.08M | -$6.3M | -$8.71M | -$7.5M | -$3.4M | -$7.24M | -$2.63M | -$1.78M | -$3.02M |
| Free Cash Flow | -$88.81M | -$17.44M | $186.65M | -$305.26M | -$220.98M | -$81.65M | -$89.48M | -$39.21M | -$13.96M | -$13.9M | -$12.71M | $9.63M | $2.53M | $3.58M | -$1.1M | -$28.52M | $4.12M | -$17.66M | -$15.83M | -$6.26M | -$15.38M | -$13.1M |
| Cash at Beginning | $153.96M | $283.59M | $313.28M | $377.54M | $235.63M | $121.16M | $86.04M | $85.27M | $79.43M | $31.94M | $38.95M | $46.86M | $30.77M | $53.76M | $15.27M | $17.25M | $33.19M | $45.74M | $64.05M | -$1.5M | $8.89M | $0 |
| Cash at End | $71.33M | $153.96M | $283.59M | $313.28M | $377.54M | $235.63M | $121.16M | $86.04M | $85.27M | $79.43M | $31.94M | $38.95M | $46.86M | $62.01M | $23.72M | $20.81M | $36.73M | $30.6M | $46.78M | $63.5M | -$1.77M | $16.28M |